A comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation

Transplantation

Volumn 80, Issue 11, 2005, Pages 1572-1577

  Gloor, James M ^a   Lager, Donna J ^a   Fidler, Mary E ^a   Grande, Joseph P ^a   Moore, S Breanndan ^a   Winters, Jeffrey L ^a   Kremers, Walter K ^a   Stegall, Mark D ^a  

^a MAYO CLINIC   (United States)

Author keywords

ABO incompatible; Kidney transplantation; Plasmapheresis; Splenectomy

Indexed keywords

CD20 ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GRAFT SURVIVAL; HIGH RISK POPULATION; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; SPLENECTOMY; TREATMENT OUTCOME;

ABO BLOOD-GROUP SYSTEM; BLOOD GROUP INCOMPATIBILITY; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SPLENECTOMY; SURVIVAL ANALYSIS; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 29344468857     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000184622.69708.c1     Document Type: Article

References (22)

1. Stegall MD, Dean PG, Gloor JM. ABO-incompatible kidney transplantation. Transplantation 2004; 78 (5): 635.
2. Tanabe K, Takahashi K, Sonda K, et al. Long-term results of ABO-incompatible living kidney transplantation. Transplantation 1998; 65: 224.
3. Gloor IM, Lager DJ, Moore SB, et al. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 2003; 75 (7): 971.
4. Sawada T, Fuchinoue S, Teraoka S. Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis. Transplantation 2002; 74 (9): 1207.
5. Takahashi K, Saito K, Takahara S, et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 2004; 4: 1089.
6. Alexandre GPJ, Squifflet JP, De Bruyere M, et al. Splenectomy as a prerequisite for successful human ABO-incompatible renal transplantation. Transplantation Proceedings 1985; 17 (1): 138.
7. Vengelen-Tyler V. Technical Manual. 13th ed. Bethesda: American Association of Blood Banks, 1999.
8. Winters JL, Gloor JM, Pineda AA, et al. Plasma exchange conditioning for ABO-incompatible kidney transplantation. J Clin Apheresis 2004; 19: 1.
9. Fidler ME, Gloor JM, Lager DJ, et al. Histologic findings of antibody mediated rejection in ABO blood group incompatible living donor kidney transplantation. Am J Transplant 2003; 3:1.
10. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria- an addition to the Banff '97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708.
11. Starzl TE, Marchioro TL, Holmes JH, et al. Renal homografts in patients with major donor-recipient blood group incompatibilities. Surgery 1964; 55(2).
12. Nelson PW, Landreneau MD, Luger AM, et al. Ten-year experience in transplantation of A2 kidneys into B and O recipients. Transplantation 1998; 65 (2): 256.
13. Sorensen JB, Grant WJ, Belnap LP, et al. Transplantation of ABO group A2 kidneys from living donors into group O and B recipients$. Am J Transplant 2001; 1: 296.
14. Alkhunaizi AH, De Mattos AM, Barry JM, et al. Renal transplantation across the ABO barrier using A2 kidneys. Transplantation 1999; 67 (10): 1319.
15. Koyama I, Taguchi Y, Sugahara S, et al. Weak expression of blood type B antigen in kidney tissue and successful B-incompatible kidney transplantation without special treatments. Transplant Int 1996; 9(supp 1): S25.
16. Tyden G, Kumlien G, Fehrmen I. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation 2003; 76 (4): 730.
17. Sonnenday CJ, Warren DS, Cooper M, et al. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 2004; 4: 1315.
18. Shimmura H, Tanabe K, Ishikawa N, et al. Role of anti-A/B antibody titers in results of ABO-incompatible kidney transplantation. Transplantation 2000; 70: 1331.
19. Ohdan H, Swenson KG, Kruger Gray H, et al. Mac-1-negative B-1b phenotype of natural antibody producing cells, including those responding to Gal alpha 1,3 Gal epitopes in alpha 1,3-galactosyltransferase-deficient mice. J Immunol 2000; 165 (10): 5518.
20. Vieira CA, Agarwal A, Book BK, et al. Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: Safety, Pharmacodynamics, and Pharmacokinetics. Transplantation 2004; 77 (4): 542.
21. Uchida K, Tominaga Y, Haba T, et al. ABO-incompatible renal transplantation-Dissociation of ABO antibodies. Transplan Proc 1998; 30: 2302.
22. Fan X, Ang A, Pollock-BarZiv SM, et al. Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nature Med 2004; 10: 1227.